Investor Relations & Capital Introduction in Cambridge

Cambridge, Massachusetts, is home to Harvard University and MIT and holds one of the densest concentrations of biotechnology and deep technology companies in the world. For founders in science-led businesses, it is among the most important capital markets anywhere.

Why Cambridge Matters for Capital Raising

Kendall Square, next to MIT, has become a global centre for biotechnology, with major pharmaceutical research sites, hundreds of life sciences companies and specialist venture investors within walking distance of each other.

Harvard and MIT produce a constant flow of research, founders and technical talent across biology, computing, robotics and energy.

The investor community is deeply specialised. Many investors hold scientific or medical training and evaluate technology on its merits rather than on narrative.

What Cambridge Investors Examine

The quality of the science and the data behind it are examined rigorously from the first meeting.

Team depth, intellectual property and a credible development plan are expected as a matter of course.

Engagement and Access

GCN connects founders with Cambridge angel investors, family offices and specialist allocators, alongside the wider Boston investor community, through conference programming and private sessions.

Sectors where we see consistent interest include biotechnology and therapeutics, artificial intelligence, robotics, climate technology and medical devices.

Partner with Global Capital Network

Whether you are raising into Cambridge or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.